DDInter948 DDInter1596
Human interferon beta (165 residues), cysteine 17 is substituted with serine. Produced in E. coli, no carbohydrates, MW=18.5kD
A glutamate antagonist (receptors, glutamate) used as an anticonvulsant (anticonvulsants) and to prolong the survival of patients with amyotrophic lateral sclerosis. Riluzole is marketed as Rilutek by Sanofi.
Riluzole {u} (Compound) treats {v} (Disease) amyotrophic lateral sclerosis
Riluzole {u} (Compound) binds {v} (Gene) SLC7A11
Riluzole {u} (Compound) upregulates {v} (Gene) PTK2B
Riluzole {u} (Compound) is included by {v} (Pharmacologic Class) Benzothiazoles
Riluzole {u} (Compound) downregulates {v} (Gene) MRPS16
Riluzole {u} (Compound) causes {v} (Side Effect) Eczema
Riluzole {u} may cause a minor interaction that can limit clinical effects when taken with {v} Theophylline
Riluzole {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Asparaginase Escherichia coli
Riluzole {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Osimertinib
Riluzole {u} may lead to a major life threatening interaction when taken with {v} Leflunomide
Riluzole (Compound) treats amyotrophic lateral sclerosis (Disease)
Riluzole (Compound) binds SLC7A11 (Gene)
Riluzole (Compound) upregulates PTK2B (Gene)
Riluzole (Compound) is included by Benzothiazoles (Pharmacologic Class)
Riluzole (Compound) downregulates MRPS16 (Gene)
Riluzole (Compound) causes Eczema (Side Effect)
Riluzole may cause a minor interaction that can limit clinical effects when taken with Theophylline
Riluzole may cause a moderate interaction that could exacerbate diseases when taken with Asparaginase Escherichia coli
Riluzole may cause a moderate interaction that could exacerbate diseases when taken with Osimertinib
Riluzole may lead to a major life threatening interaction when taken with Leflunomide